Smith & Nephew (LON:SN) Shares Cross Above 200-Day Moving Average of $1,160.25

Shares of Smith & Nephew plc (LON:SN – Get Rating) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,160.25 ($14.43) and traded as high as GBX 1,284 ($15.97). Smith & Nephew shares last traded at GBX 1,269 ($15.78), with a volume of 1,346,741 shares trading hands.

Wall Street Analyst Weigh In

SN has been the subject of a number of recent analyst reports. Liberum Capital raised Smith & Nephew to a “buy” rating and raised their price objective for the company from GBX 1,120 ($13.93) to GBX 1,410 ($17.54) in a research report on Wednesday, March 1st. Citigroup reaffirmed a “buy” rating on shares of Smith & Nephew in a research report on Tuesday, March 14th. Berenberg Bank raised their price objective on Smith & Nephew from GBX 1,400 ($17.41) to GBX 1,500 ($18.66) and gave the company a “buy” rating in a research report on Tuesday, May 16th. Finally, Barclays raised their price objective on Smith & Nephew from GBX 1,100 ($13.68) to GBX 1,200 ($14.93) and gave the company an “underweight” rating in a research report on Thursday, April 27th. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 1,375.50 ($17.11).

Smith & Nephew Price Performance

The company has a market capitalization of £10.66 billion, a price-to-earnings ratio of 6,100.00, a P/E/G ratio of 0.97 and a beta of 0.37. The company has a debt-to-equity ratio of 54.61, a quick ratio of 0.84 and a current ratio of 2.25. The business has a 50 day moving average price of GBX 1,218.45 and a 200-day moving average price of GBX 1,160.74.

About Smith & Nephew

(Get Rating)

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.